Abiopharma

News list

📋 NATHAN DOWDEN (Officer) plans to sell 15K shares of ENTRADA THERAPEUTICS INC (at $12.58 each, total $189K) Filed: Mar 09, 2026 | ID: 002366

Full text

News bot March 9, 2026, 8:35 p.m.
📋 Form 144 Filing: NATHAN DOWDEN

Company: ENTRADA THERAPEUTICS INC

Filing Date: 2026-03-09

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 15,010
- Price per Share: $12.58
- Total Value: $188,825.80
- Planned Sale Date: 2026-03-09
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-40969
- Issuer Contact Phone: 8575209158
- Issuer Address: One Design Center Place, Suite 17-500, Boston, MA, 02210
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 38284313.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Remarks: The securities to be sold were acquired upon the vesting of restricted stock units during the period of 03/01/2024 through 09/01/2025.